IP Library Granted Patent US 7,974,705
Granted Patent B2
US 7,974,705 · App. 12/665,030 · Granted Jul 5, 2011

Multiplexed multi-electrode neurostimulation devices

Assignee: Proteus Biomedical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,974,705
App. No.
12/665,030
Granted
Jul 5, 2011
Kind
B2
Abstract

Implantable stimulation devices are provided. Aspects of the devices include a multiplexed multi-electrode component configured for neural stimulation. The multiplexed multi-electrode component includes two or more individually addressable satellite electrode structures electrically coupled to a common conductor. The satellite structures include a hermetically sealed integrated circuit controller operatively coupled to one or more electrodes. Also provided are systems that include the devices of the invention, as well as methods of using the systems and devices in a variety of different applications.

Claims (23)

1. An implantable device for target site stimulation, the device comprising:

a multiplexed lead comprising at least one conductor;

a plurality of multiplexed addressable units secured at predetermined locations along the conductor, wherein each addressable unit comprises:

a multi-port connector defining a plurality of ports, wherein each port receives an electrode lead that is electrically coupled to and secured to the multi-port connector and each electrode lead includes a plurality of independently excitable electrodes; and

a plurality of independently addressable integrated circuits corresponding to the number of defined ports in a the multi-port connector, wherein each circuit is electrically coupled to the corresponding electrode lead at the corresponding port and wherein each circuit controls the power flowing to each of the plurality of independently excitable electrodes of the respective electrode lead in the corresponding port; and

a hermetically sealed control unit electrically coupled to the conductor, wherein the control unit provides control information and power to each of the plurality of multiplexed addressable units through the conductor;

wherein the target site is a spinal nerve and wherein the device is shaped to at least partially surround the spinal nerve and wherein the multiplexed lead further comprises a second conductor secured and electrically coupled to at least a portion of the plurality of addressable units.

2. The implantable device of claim 1 wherein the multiplexed addressable units are arranged and multiplexed in a branched configuration.

3. An implantable device for target site stimulation, the device comprising:

a multiplexed lead comprising at least one conductor;

a plurality of multiplexed addressable units secured at predetermined locations along the conductor, wherein each addressable unit comprises:

a multi-port connector defining a plurality of ports, wherein each port receives an electrode lead that is electrically coupled to and secured to the multi-port connector and each electrode lead includes a plurality of independently excitable electrodes; and

a plurality of independently addressable integrated circuits corresponding to the number of defined ports in a the multi-port connector, wherein each circuit is electrically coupled to the corresponding electrode lead at the corresponding port and wherein each circuit controls the power flowing to each of the plurality of independently excitable electrodes of the respective electrode lead in the corresponding port; and

a hermetically sealed control unit electrically coupled to the conductor, wherein the control unit provides control information and power to each of the plurality of multiplexed addressable units through the conductor;

wherein:

at least one electrode lead comprises four independently excitable electrodes that are uniformly and axially positioned about the respective electrode lead; and

at least one other electrode lead comprises six independently excitable electrodes.

4. The implantable device of claim 3 wherein the six independently excitable electrodes are uniformly and axially positioned about the respective electrode lead.

5. The implantable device of claim 3 wherein the plurality of independently excitable electrodes of at least one electrode are positioned radially about the respective electrode lead.

6. The implantable device of claim 3 wherein the plurality of independently excitable electrodes of at least one electrode lead are positioned on one side of the respective electrode lead.

7. The implantable device of claim 3 wherein the plurality of independently excitable electrodes of at least one electrode lead are staggered along the respective electrode lead.

8. The implantable device of claim 7 wherein the system further comprises a power storage unit coupled to the conductor of the lead for supplying power to the electrode structures through the integrated circuit controller.

9. The implantable device of claim 7 wherein the plurality of independently addressable integrated circuits are hermetically sealed.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2024
From: PROTEUS DIGITAL HEALTH INC.,
To: OTSUKA AMERICA PHARMACEUTICAL, INC.
Reel/Frame 068980/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2024
From: OTSUKA AMERICA PHARMACEUTICAL, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 068980/0277 →
CHANGE OF NAME Recorded Nov 2, 2012
From: PROTEUS BIOMEDICAL, INC.
To: PROTEUS DIGITAL HEALTH, INC.
Reel/Frame 029228/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2010
From: ZDEBLICK, MARK; THOMPSON, TODD; JENSEN, MARC; COLLIOU, OLIVIER; STRAND, ANGELA
To: PROTEUS BIOMEDICAL, INC.
Reel/Frame 023743/0088 →
Continuity (2)
Provisional Application 61114433 · Nov 13, 2008
Related Publication 20110022124A1 · Jan 27, 2011